Dietary from affects inflammatory status in a rat model of colitis

Journal of Nutrition

Volumn 134, Issue 9, 2004, Pages 2251-2255

  Uritski, Ram ^a   Barshack, Iris ^b   Bilkis, Itzhak ^a   Ghebremeskel, Kebreab ^c   Reifen, Ram ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Inflammatory bowel disease; Iron; Oxidative stress; Rat model

Indexed keywords

FERRITIN; IRON; MALONALDEHYDE; MYELOPEROXIDASE; THIOL GROUP; TRINITROBENZENESULFONIC ACID; PEROXIDASE; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; FERRITIN BLOOD LEVEL; HISTOPATHOLOGY; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON INTAKE; IRON OVERLOAD; IRON THERAPY; KIDNEY; LIVER LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; COLON; DOSE RESPONSE; LIVER; METABOLISM; OSMOLARITY; PATHOLOGY; WISTAR RAT;

ANIMALIA;

ANIMALS; COLITIS; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRITINS; IRON; IRON, DIETARY; KIDNEY; LIVER; MALE; MALONDIALDEHYDE; OSMOLAR CONCENTRATION; OXIDATIVE STRESS; PEROXIDASE; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; TRINITROBENZENESULFONIC ACID;

EID: 4444244246     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.9.2251     Document Type: Article

References (40)

1. Kokoszka, J. & Nelson, R. L. (1993) Determination of inflammatory bowel disease activity by breath pentane analysis. Dis. Colon Rectum 36: 597-601.
2. Fiocchi, C. (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroentrology 115: 182-205.
3. D'Odorico, A., Bortolan, S., Cardin, R., D'Inca, R., Martines, D., Ferronato, A. & Sturniolo, G. C. (2001) Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand. J. Gastroenterol. 36: 1289-1294.
4. Horina, J. H., Petritsch, W., Schmid, C. R., Reicht, G., Wenzl, H., Silly, H. & Krejs, G. J. (1993) Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: results in three patients. Gastroenterology 104: 1828-1831.
5. Schreiber, S., Howaldt, S., Schnoor, M., Nikolaus, S., Bauditz, J., Gasche, C., Lochs, H. & Raedler, A. (1996) Recombinant erythropoietin for the treatment of anemia in inflammatory disease. N. Engl. J. Med. 334: 619-623.
6. Revel-Vilk, S., Tamary, H., Broide, E., Zoldan, M., Dinari, G., Zahavi, I., Yaniv, I. & Shamir, R. (2000) Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur. J. Pediatr. 159: 585-589.
7. Mamula, P., Piccoli, D. A., Peck, S. N., Markowitz, J. E. & Baldassano, R. N. (2002) Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 34: 286-290.
8. Christodoulou, D. K. & Tsianos, E. V. (2000) Anemia in inflammatory bowel disease - the role of recombinant human erythropoietin. Eur. J. Intern. Med. 11: 222-227.
9. Konijn, A. M. (1994) Iron metabolism in inflammation. Bailliere's Clin. Haematol. 7: 829-849.
10. Gasche, C., Reinisch, W., Lochs, H., Parsaei, B., Bakos, S., Wyatt, J., Fueger, G. F. & Gangl, A. (1994) Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig. Dis. Sci. 39: 1930-1934.
11. Oldenburg, B., Koningsberger, J. C., Van Berge Henegouwen, G. P., Van Asbeck, B. S. & Marx, J. J. (2001) Review article: iron and inflammatory bowel disease. Aliment. Pharmacol. Ther. 15: 429-438.
12. Tilg, H., Ulmer, H., Kaser, A. & Weiss, G. (2002) Role of IL-10 for induction of anemia during inflammation. J. Immunol. 169: 2204-2209.
13. Halliwell, B. & Gutteridge, J.M.C. (1989) In: Free Radicals in Biology and Medicine. Clarendon Press, Oxford, UK.
14. Liochev, S.I. (1999) The mechanism of "Fenton-like" reactions and their importance for biological systems. A biologist's view. Metal Ions Biol. Syst. 36: 1-39.
15. Emerti, J., Beaumont, C. & Trivin, F. (2001) Iron metabolism, free radicals and oxidative injury. Biomed. Pharmacother. 55: 333-339.
16. Knutson, M. D., Walter, P. B., Ames, B. N. & Viteri, F. E. (2000) Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J. Nutr. 130: 621-628.
17. Aghdassy, E., Carrier, J., Cullen, J. & Allard, J. P. (2001) Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis. Dig. Dis. Sci. 46: 1088-1094.
18. Carrier, J., Aghdassy, E., Cullen, J. & Allard, J. P. (2002) Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate and sodium-induced colitis. J. Nutr. 132: 3146-3150.
19. Seril, D. N., Liao, J., Ho, K. L., Warsi, A., Yang, C. S. & Yang, G. Y. (2002) Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig. Dis. Sci. 47: 1266-1278.
20. Ablin, J., Shalev, O., Okon, E., Karmeli, F. & Rachmilewitz, D. (1999) Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm. Bowel Dis. 5: 253-261.
21. Millar, A. D., Rampton, D. S. & Blake, R. D. (2000) Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment. Pharmacol. Ther. 14: 1163-1168.
22. Reifen, R., Matas, Z., Zeidel, L., Berkovitch, Z. & Bujanover, Y. (2000) Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig. Dis. Sci. 45: 394-397.
23. Morris, G., Beck, P., Herridge, M., Depew, W., Szewczuk, M. & Wallace, J. (1989) Hapten induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803.
24. Vacha, J., Dungel, J. & Kleinwachter, V. (1978) Determination of heme and non-heme iron content of mouse erythropoietic organs. Exp. Hematol. 6: 718-724.
25. Bradley, P., Priebat, D, Christensen, R. & Rothestein, G. (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Investig. Dermatol. 78: 206-209.
26. Weiner, L. M. (1995) Quantitative determination of thiol groups in low and high molecular weight compounds by EPR. Methods Enzymol. 251: 87-105.
27. Buege, J. & Aust, S. (1978) Microsomal lipid peroxidation. Methods Enzymol. 52: 302-306.
28. Gasche, C. (2000) Anemia in IBD: the overlooked villain. Inflamm. Bowel Dis. 6: 142-150.
29. Gasche, C., Waldhoer, T., Feichtenschlager, T., Male, C., Mayer, A., Mittermaier, C. & Petritsch, W. (2001) Prediction of response to iron sucrose in inflammatory bowel disease associated anemia. Am. J. Gastroenterol. 96: 2382-2387.
30. Macdougall, I.C. (1999) Strategies for iron supplemenation: oral versus intravenous. Kidney Int. 69: S61-S66.
31. Hagen, K., Zhu, C., Melefors, O. & Hultcrantz, R. (1999) Susceptibility of cultured rat hepatocytes to oxidative stress by peroxides and iron. The extra-cellular matrix effects of toxicity of tert-butyl hydroperoxide. Int. J. Biochem. Mol. Biol. 31: 499-508.
32. Staubli, A. & Boelsterli, U. A. (1998) The labile iron pool in hepatocytes: prooxidant-induced increase in free iron precedes oxidative cell injury. Am. J. Physiol. 274: G1031-G1037.
33. Surico, G., Muggeo, P., Muggeo, V., Lucarelli, A., Martucci, T., Daniele, M. & Rigillo, N. (2002) Parenteral iron supplementation for the treatment of iron deficiency anemia in children. Ann. Hematol. 81: 154-157.
34. Burns, D. L. & Pomposelli, J. J. (1999) Toxicity of parenteral dextran therapy. Kidney Int. Suppl. 69: S119-S124.
35. Babbs, C. F. (1990) Free radicals and etiology of colon cancer. Free Radic. Biol. Med. 8: 191-200.
36. Biemond, P., van Eijk, H. G., Swaak, A. J. & Koster, J. F. (1984) Iron mobilization from ferritin by superoxide derived from stimulated polymorphonu-clear leukocytes. Possible mechanism in inflammation diseases. J. Clin. Investig. 73: 1576-1579.
37. Blakeborough, M. H., Owen, R. W. & Bilton, R. F. (1989) Free radical generating mechanisms in the colon: their role in the induction and promotion of colorectal cancer. Free Radic. Res. Commun. 6: 359-367.
38. Lund, E. K., Wharf, S. G., Fairweather-Tait, S. J. & Johnson, I. T. (1992) Increases in the concentration of available iron in response to dietary iron supplementation associated with changes in crypt cell proliferation in rat large intestine. J. Nutr. 128: 175-179.
39. Viteri, F. E., Liu, X., Tolomei, K. & Martin, A. (1995) True absorption and retention of supplemental iron is more efficient when iron is administered every three days rather than daily to iron-normal and iron-deficient rats. J. Nutr. 125: 82-91.
40. Viteri, F. E. (1998) A new concept in the control of iron deficiency: community based preventive supplementation of at-risk groups by the weekly intakes of iron supplements. Biomed. Environ. Sci. 11: 46-60.